Michael A. Caligiuri

Michael A. Caligiuri

Fondateur chez
Cytoimmune Therapeutics, Inc.
70 ans
Health Technology
Commercial Services
Health Services

Profil

Michael A. Caligiuri is the founder of Cytoimmune Therapeutics, Inc., a company founded in 2019 where he holds the title of Chief Medical Officer.
He currently holds the position of Director-Comprehensive Cancer Center at The Ohio University, Director at The Ohio State University Wexner Medical Center, and Director at Pelotonia.
In the past, he served as Chief Executive Officer at James Cancer Hospital, Chief Executive Officer & Director at Ohio State University Comprehensive Cancer Center, Independent Member-Supervisory Board at Innate Pharma SA, President-Elect at American Association for Cancer Research, and Co-President at City of Hope National Medical Center.

Postes actifs de Michael A. Caligiuri

SociétésPosteDébut
Corporate Officer/Principal -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Fondateur 01/06/2019

Anciens postes connus de Michael A. Caligiuri

SociétésPosteFin
President 18/04/2018
Directeur Général 15/11/2017
President -
Directeur Général -
INNATE PHARMA Directeur/Membre du Conseil -
Voir l'expérience en détail de Michael A. Caligiuri

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

53

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Consumer Services

Health Technology

Health Services

Commercial Services

Health Services

Commercial Services

Commercial Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Michael A. Caligiuri
🔇